Adem E, Yizengaw E, Mulaw T, Nibret E, Muller I, Takele Y
PLoS Negl Trop Dis. 2024; 18(8):e0012417.
PMID: 39159266
PMC: 11373857.
DOI: 10.1371/journal.pntd.0012417.
Lun X, Shi Y, Wang Y, Zhao N, Liu Q, Meng F
Parasit Vectors. 2024; 17(1):250.
PMID: 38849919
PMC: 11157846.
DOI: 10.1186/s13071-024-06331-4.
St Clair E, Baer A, Ng W, Noaiseh G, Baldini C, Tarrant T
Nat Med. 2024; 30(6):1583-1592.
PMID: 38839899
PMC: 11186761.
DOI: 10.1038/s41591-024-03009-3.
Jiang F, Hu S, Tian W, Wang N, Yang N, Dong S
Nat Commun. 2024; 15(1):1409.
PMID: 38360850
PMC: 10869817.
DOI: 10.1038/s41467-024-45652-x.
Kivitz A, Wang L, Alevizos I, Gunsior M, Falloon J, Illei G
RMD Open. 2023; 9(3).
PMID: 37541743
PMC: 10407378.
DOI: 10.1136/rmdopen-2023-003317.
Bovine Immunity and Vitamin D: An Emerging Association in Johne's Disease.
Wherry T, Stabel J
Microorganisms. 2022; 10(9).
PMID: 36144467
PMC: 9500906.
DOI: 10.3390/microorganisms10091865.
Inhibitory effects of superoxide dismutase 3 on IgE production in B cells.
Agrahari G, Sah S, Lee M, Bang C, Kim Y, Kim H
Biochem Biophys Rep. 2022; 29:101226.
PMID: 35155837
PMC: 8822298.
DOI: 10.1016/j.bbrep.2022.101226.
Engaging innate immunity in HIV-1 cure strategies.
Board N, Moskovljevic M, Wu F, Siliciano R, Siliciano J
Nat Rev Immunol. 2021; 22(8):499-512.
PMID: 34824401
DOI: 10.1038/s41577-021-00649-1.
Targeting the CD40-CD154 Signaling Pathway for Treatment of Autoimmune Arthritis.
Lai J, Luo S, Ho L
Cells. 2019; 8(8).
PMID: 31426619
PMC: 6721639.
DOI: 10.3390/cells8080927.
The Incorporation of Host Proteins into the External HIV-1 Envelope.
Burnie J, Guzzo C
Viruses. 2019; 11(1).
PMID: 30669528
PMC: 6356245.
DOI: 10.3390/v11010085.
Characterization of a Broadly Reactive Anti-CD40 Agonistic Monoclonal Antibody for Potential Use as an Adjuvant.
Martin C, Waghela S, Lokhandwala S, Ambrus A, Bray J, Vuong C
PLoS One. 2017; 12(1):e0170504.
PMID: 28107431
PMC: 5249191.
DOI: 10.1371/journal.pone.0170504.
Immunotherapy for Bone and Soft Tissue Sarcomas.
Uehara T, Fujiwara T, Takeda K, Kunisada T, Ozaki T, Udono H
Biomed Res Int. 2015; 2015:820813.
PMID: 26167500
PMC: 4488089.
DOI: 10.1155/2015/820813.
Human CD141+ dendritic cells induce CD4+ T cells to produce type 2 cytokines.
Yu C, Becker C, Metang P, Marches F, Wang Y, Toshiyuki H
J Immunol. 2014; 193(9):4335-43.
PMID: 25246496
PMC: 4201960.
DOI: 10.4049/jimmunol.1401159.
Inflammatory colonic carcinogenesis: a review on pathogenesis and immunosurveillance mechanisms in ulcerative colitis.
Scarpa M, Castagliuolo I, Castoro C, Pozza A, Scarpa M, Kotsafti A
World J Gastroenterol. 2014; 20(22):6774-85.
PMID: 24944468
PMC: 4051917.
DOI: 10.3748/wjg.v20.i22.6774.
Synergic silencing of costimulatory molecules prevents cardiac allograft rejection.
Zhang X, Liu Y, Zhang G, Shi J, Zhang X, Zheng X
J Transl Med. 2014; 12:142.
PMID: 24886282
PMC: 4040111.
DOI: 10.1186/1479-5876-12-142.
Soluble CD40 ligand: a novel biomarker in the pathogenesis of periodontal disease.
Chaturvedi R, Gupta M, Jain A, Das T, Prashar S
Clin Oral Investig. 2014; 19(1):45-52.
PMID: 24595688
DOI: 10.1007/s00784-014-1216-3.
Ex vivo enzymatic treatment of aged CD4 T cells restores cognate T cell helper function and enhances antibody production in mice.
Perkey E, Miller R, Garcia G
J Immunol. 2012; 189(12):5582-9.
PMID: 23136198
PMC: 3518580.
DOI: 10.4049/jimmunol.1200487.
Serum concentrations and clinical significance of soluble CD40 ligand in patients with multiple myeloma.
Tsirakis G, Pappa C, Psarakis F, Fragioudaki M, Tsioutis C, Stavroulaki E
Med Oncol. 2012; 29(4):2396-401.
PMID: 22403003
DOI: 10.1007/s12032-012-0203-2.
Stimulation-dependent induction of CD154 on a subset of CD4+ FoxP3+ T-regulatory cells.
Li W, Carlson T, Green W
Int Immunopharmacol. 2011; 11(9):1205-10.
PMID: 21496498
PMC: 3827958.
DOI: 10.1016/j.intimp.2011.03.021.
Fexofenadine hydrochloride in the treatment of allergic disease: a review.
Axelrod D, Bielory L
J Asthma Allergy. 2011; 1:19-29.
PMID: 21436982
PMC: 3121339.
DOI: 10.2147/jaa.s3092.
